The Wall Street Journal released report that had raised questions about whether the innovative blood test startup Theranos was delivering as promised when it came to tests done from blood drawn by simple pin pricks. The newspaper accused the Silicon Valley-based startup of using nothing more revolutionary than widely available commercial equipment. Elizabeth Holmes, the founder of Theranos challenged The Journal on its own turf about an investigation into the firm's technology.
Holmes took to the stage at the prestigious WSJDLive technology conference on the Southern California coast on Wednesday, October 21, 2015, to say the Journal got the story wrong. Holmes said during an interview with Wall Street Journal global technology editor Jonathan Krim, "We know the integrity of what we have done and regulators have looked at it."
The Journal released a statement standing by its report. It said, "Nothing said at the conference by Ms. Holmes refutes the accuracy of the reporting done by John Carreyrou or of the articles. The Journal reiterates that our articles about Theranos were thoroughly reported, fair and wholly accurate."
Holmes maintained otherwise during the on-stage interview. She said, "Concerns about Theranos testing methodology in the report were 'completely false'. We know what we are doing and are very proud of it, using finger prick testing and trying to expand the universe of how many tests are available."